Cargando…

T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis

BACKGROUND: Myocardial black blood (BB) T2* relaxometry at 1.5T provides robust, reproducible and calibrated non-invasive assessment of cardiac iron burden. In vitro data has shown that like T2*, novel native Modified Look-Locker Inversion recovery (MOLLI) T1 shortens with increasing tissue iron. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Mohammed H., Auger, Dominique, Smith, Gillian C., He, Taigang, Vassiliou, Vassilis, Baksi, A. John, Wage, Rick, Drivas, Peter, Feng, Yanqiu, Firmin, David N., Pennell, Dudley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659152/
https://www.ncbi.nlm.nih.gov/pubmed/26602203
http://dx.doi.org/10.1186/s12968-015-0207-0
_version_ 1782402579634847744
author Alam, Mohammed H.
Auger, Dominique
Smith, Gillian C.
He, Taigang
Vassiliou, Vassilis
Baksi, A. John
Wage, Rick
Drivas, Peter
Feng, Yanqiu
Firmin, David N.
Pennell, Dudley J.
author_facet Alam, Mohammed H.
Auger, Dominique
Smith, Gillian C.
He, Taigang
Vassiliou, Vassilis
Baksi, A. John
Wage, Rick
Drivas, Peter
Feng, Yanqiu
Firmin, David N.
Pennell, Dudley J.
author_sort Alam, Mohammed H.
collection PubMed
description BACKGROUND: Myocardial black blood (BB) T2* relaxometry at 1.5T provides robust, reproducible and calibrated non-invasive assessment of cardiac iron burden. In vitro data has shown that like T2*, novel native Modified Look-Locker Inversion recovery (MOLLI) T1 shortens with increasing tissue iron. The relative merits of T1 and T2* are largely unexplored. We compared the established 1.5T BB T2* technique against native T1 values at 1.5T and 3T in iron overload patients and in normal volunteers. METHODS: A total of 73 subjects (42 male) were recruited, comprising 20 healthy volunteers (controls) and 53 patients (thalassemia major 22, sickle cell disease 9, hereditary hemochromatosis 9, other iron overload conditions 13). Single mid-ventricular short axis slices were acquired for BB T2* at 1.5T and MOLLI T1 quantification at 1.5T and 3T. RESULTS: In healthy volunteers, median T1 was 1014 ms (full range 939–1059 ms) at 1.5T and modestly increased to 1165ms (full range 1056–1224 ms) at 3T. All patients with significant cardiac iron overload (1.5T T2* values <20 ms) had T1 values <939 ms at 1.5T, and <1056 ms at 3T. Associations between T2* and T1 were found to be moderate with y =377 · x(0.282) at 1.5T (R(2) = 0.717), and y =406 · x(0.294) at 3T (R(2) = 0.715). Measures of reproducibility of T1 appeared superior to T2*. CONCLUSIONS: T1 mapping at 1.5T and at 3T can identify individuals with significant iron loading as defined by the current gold standard T2* at 1.5T. However, there is significant scatter between results which may reflect measurement error, but it is also possible that T1 interacts with T2*, or is differentially sensitive to aspects of iron chemistry or other biology. Hurdles to clinical implementation of T1 include the lack of calibration against human myocardial iron concentration, no demonstrated relation to cardiac outcomes, and variation in absolute T1 values between scanners, which makes inter-centre comparisons difficult. The relative merits of T1 at 3T versus T2* at 3T require further consideration.
format Online
Article
Text
id pubmed-4659152
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46591522015-11-30 T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis Alam, Mohammed H. Auger, Dominique Smith, Gillian C. He, Taigang Vassiliou, Vassilis Baksi, A. John Wage, Rick Drivas, Peter Feng, Yanqiu Firmin, David N. Pennell, Dudley J. J Cardiovasc Magn Reson Research BACKGROUND: Myocardial black blood (BB) T2* relaxometry at 1.5T provides robust, reproducible and calibrated non-invasive assessment of cardiac iron burden. In vitro data has shown that like T2*, novel native Modified Look-Locker Inversion recovery (MOLLI) T1 shortens with increasing tissue iron. The relative merits of T1 and T2* are largely unexplored. We compared the established 1.5T BB T2* technique against native T1 values at 1.5T and 3T in iron overload patients and in normal volunteers. METHODS: A total of 73 subjects (42 male) were recruited, comprising 20 healthy volunteers (controls) and 53 patients (thalassemia major 22, sickle cell disease 9, hereditary hemochromatosis 9, other iron overload conditions 13). Single mid-ventricular short axis slices were acquired for BB T2* at 1.5T and MOLLI T1 quantification at 1.5T and 3T. RESULTS: In healthy volunteers, median T1 was 1014 ms (full range 939–1059 ms) at 1.5T and modestly increased to 1165ms (full range 1056–1224 ms) at 3T. All patients with significant cardiac iron overload (1.5T T2* values <20 ms) had T1 values <939 ms at 1.5T, and <1056 ms at 3T. Associations between T2* and T1 were found to be moderate with y =377 · x(0.282) at 1.5T (R(2) = 0.717), and y =406 · x(0.294) at 3T (R(2) = 0.715). Measures of reproducibility of T1 appeared superior to T2*. CONCLUSIONS: T1 mapping at 1.5T and at 3T can identify individuals with significant iron loading as defined by the current gold standard T2* at 1.5T. However, there is significant scatter between results which may reflect measurement error, but it is also possible that T1 interacts with T2*, or is differentially sensitive to aspects of iron chemistry or other biology. Hurdles to clinical implementation of T1 include the lack of calibration against human myocardial iron concentration, no demonstrated relation to cardiac outcomes, and variation in absolute T1 values between scanners, which makes inter-centre comparisons difficult. The relative merits of T1 at 3T versus T2* at 3T require further consideration. BioMed Central 2015-11-24 /pmc/articles/PMC4659152/ /pubmed/26602203 http://dx.doi.org/10.1186/s12968-015-0207-0 Text en © Alam et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Alam, Mohammed H.
Auger, Dominique
Smith, Gillian C.
He, Taigang
Vassiliou, Vassilis
Baksi, A. John
Wage, Rick
Drivas, Peter
Feng, Yanqiu
Firmin, David N.
Pennell, Dudley J.
T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis
title T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis
title_full T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis
title_fullStr T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis
title_full_unstemmed T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis
title_short T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis
title_sort t1 at 1.5t and 3t compared with conventional t2* at 1.5t for cardiac siderosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659152/
https://www.ncbi.nlm.nih.gov/pubmed/26602203
http://dx.doi.org/10.1186/s12968-015-0207-0
work_keys_str_mv AT alammohammedh t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT augerdominique t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT smithgillianc t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT hetaigang t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT vassiliouvassilis t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT baksiajohn t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT wagerick t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT drivaspeter t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT fengyanqiu t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT firmindavidn t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis
AT pennelldudleyj t1at15tand3tcomparedwithconventionalt2at15tforcardiacsiderosis